PubMed

Bayesian profiling of molecular signatures to predict event times.

Zhang D, Zhang M.

Theor Biol Med Model. 2007 Jan 19;4:3.PMID: 17239251 [PubMed - indexed for MEDLINE]Related articlesFree article

Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited.

Segal MR.

Biostatistics. 2006 Apr;7(2):268-85. Epub 2005 Nov 11.PMID: 16284340 [PubMed - indexed for MEDLINE]Related articlesFree article

Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma.

Ando T, Suguro M, Hanai T, Kobayashi T, Honda H, Seto M.

Jpn J Cancer Res. 2002 Nov;93(11):1207-12.PMID: 12460461 [PubMed - indexed for MEDLINE]Related articles

Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature.

Suguro M, Tagawa H, Kagami Y, Okamoto M, Ohshima K, Shiku H, Morishima Y, Nakamura S, Seto M.

Cancer Sci. 2006 Sep;97(9):868-74. Epub 2006 Jul 13.PMID: 16856881 [PubMed - indexed for MEDLINE]Related articles

Iterative Bayesian Model Averaging: a method for the application of survival analysis to high-dimensional microarray data.

Annest A, Bumgarner RE, Raftery AE, Yeung KY.

BMC Bioinformatics. 2009 Feb 26;10:72.PMID: 19245714 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessment of survival prediction models based on microarray data.

Schumacher M, Binder H, Gerds T.

Bioinformatics. 2007 Jul 15;23(14):1768-74. Epub 2007 May 7.PMID: 17485430 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.

Sakhinia E, Glennie C, Hoyland JA, Menasce LP, Brady G, Miller C, Radford JA, Byers RJ.

Blood. 2007 May 1;109(9):3922-8. Epub 2007 Jan 25.PMID: 17255358 [PubMed - indexed for MEDLINE]Related articlesFree article

CASPAR: a hierarchical bayesian approach to predict survival times in cancer from gene expression data.

Kaderali L, Zander T, Faigle U, Wolf J, Schultze JL, Schrader R.

Bioinformatics. 2006 Jun 15;22(12):1495-502. Epub 2006 Mar 22. Erratum in: Bioinformatics. 2007 Jan 15;23(2):266. PMID: 16554338 [PubMed - indexed for MEDLINE]Related articlesFree article

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.

Poirel HA, Cairo MS, Heerema NA, Swansbury J, Aupérin A, Launay E, Sanger WG, Talley P, Perkins SL, Raphaël M, McCarthy K, Sposto R, Gerrard M, Bernheim A, Patte C; FAB/LMB 96 International Study Committee.

Leukemia. 2009 Feb;23(2):323-31. Epub 2008 Nov 20.PMID: 19020548 [PubMed - indexed for MEDLINE]Related articles

Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.

Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T.

Arch Dermatol. 2007 Sep;143(9):1144-50.PMID: 17875875 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma.

Last K, Debarnardi S, Lister TA.

Methods Mol Med. 2005;115:15-63.PMID: 15998962 [PubMed - indexed for MEDLINE]Related articles

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.

Pfreundschuh M, Ho AD, Cavallin-Stahl E, Wolf M, Pettengell R, Vasova I, Belch A, Walewski J, Zinzani PL, Mingrone W, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Corrado C, Scheliga A, Loeffler M, Kuhnt E; MabThera International Trial (MInT) Group.

Lancet Oncol. 2008 May;9(5):435-44. Epub 2008 Apr 8.PMID: 18400558 [PubMed - indexed for MEDLINE]Related articles

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A.

JAMA. 2008 Apr 2;299(13):1574-87.PMID: 18387932 [PubMed - indexed for MEDLINE]Related articlesFree article

Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.

Fu K, Iqbal J, Chan WC.

Expert Rev Mol Diagn. 2005 May;5(3):397-408. Review.PMID: 15934816 [PubMed - indexed for MEDLINE]Related articles

Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information.

Li L.

Bioinformatics. 2006 Feb 15;22(4):466-71. Epub 2005 Dec 8.PMID: 16339281 [PubMed - indexed for MEDLINE]Related articlesFree article

Kernel mixture survival models for identifying cancer subtypes, predicting patient's cancer types and survival probabilities.

Ando T, Imoto S, Miyano S.

Genome Inform. 2004;15(2):201-10.PMID: 15706506 [PubMed - indexed for MEDLINE]Related articles

Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.

Ang MK, Hee SW, Quek R, Yap SP, Loong S, Tan L, Tao M, Lim ST.

Ann Hematol. 2009 May;88(5):417-24. Epub 2008 Sep 7.PMID: 18777110 [PubMed - indexed for MEDLINE]Related articles

Serum IL-6, IL-8, IL-10 and beta2-microglobulin in association with International Prognostic Index in diffuse large B cell lymphoma.

Duletić-Nacinović A, Stifter S, Marijić B, Lucin K, Valković T, Petranović D, Jonjić N.

Tumori. 2008 Jul-Aug;94(4):511-7.PMID: 18822687 [PubMed - indexed for MEDLINE]Related articles

Diagnostic and prognostic significance of gene expression profiling in lymphomas.

Leich E, Hartmann EM, Burek C, Ott G, Rosenwald A.

APMIS. 2007 Oct;115(10):1135-46. Review.PMID: 18042147 [PubMed - indexed for MEDLINE]Related articles

CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma.

Wilson KS, Sehn LH, Berry B, Chhanabhai M, Fitzgerald CA, Gill KK, Klasa R, Skinnider B, Sutherland J, Connors JM, Gascoyne RD.

Leuk Lymphoma. 2007 Jun;48(6):1102-9.PMID: 17577773 [PubMed - indexed for MEDLINE]Related articles